Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod S A, Simard J
Laboratory of Molecular Endocrinology, CHUL Research Center, Quebec, Canada.
J Med Genet. 1996 Oct;33(10):814-9. doi: 10.1136/jmg.33.10.814.
Germline mutations in the BRCA1 tumour suppressor gene on chromosome 17q21 are responsible for approximately half of the cases of hereditary breast cancer, including the majority of familial breast/ovarian cancers. To increase our knowledge of the spectrum of BRCA1 mutations, we have extended our analysis to include patients with varied family histories of cancer of the breast, ovary, and at multiple other sites. We have analysed 23 unrelated familial cases using direct sequencing or a combination of dideoxy fingerprinting and sequencing procedures. Twenty one of these families contained three or more cases of breast or ovarian cancer and two families had one case of breast cancer diagnosed before the age of 40 and one case of ovarian cancer. The common frameshift mutation 5382insC was detected in two patients, and the 185delAG mutation was found in a family of Ashkenazi Jewish descent. The novel frameshift mutation 3450del4 (CAAG) was detected in a patient who developed breast cancer at the age of 28 and ovarian cancer at the age of 34. Three other women in this family were diagnosed with breast cancer at the ages of 26, 29, and 40. The novel framshift mutation 2953del3+C was found in a French Canadian woman who had developed two primary cancers of the breast at the age of 37 and 38 and renal cancer at the age of 38.
位于17号染色体q21区域的肿瘤抑制基因BRCA1的种系突变,约占遗传性乳腺癌病例的一半,包括大多数家族性乳腺癌/卵巢癌。为了增加我们对BRCA1突变谱的了解,我们扩大了分析范围,纳入了有不同乳腺癌、卵巢癌及其他多个部位癌症家族史的患者。我们使用直接测序或双脱氧指纹图谱与测序程序相结合的方法,分析了23个无亲缘关系的家族性病例。其中21个家族包含三例或更多例乳腺癌或卵巢癌病例,两个家族有一例40岁前诊断出的乳腺癌和一例卵巢癌。在两名患者中检测到常见的移码突变5382insC,在一个阿什肯纳兹犹太裔家族中发现了185delAG突变。在一名28岁患乳腺癌、34岁患卵巢癌的患者中检测到新的移码突变3450del4(CAAG)。该家族中的另外三名女性分别在26岁、29岁和40岁时被诊断出患有乳腺癌。在一名法裔加拿大女性中发现了新的移码突变2953del3+C,她在37岁和38岁时患了两例原发性乳腺癌,38岁时患了肾癌。